PUCCF
Carolina Rush Corp$0.0600 −0.01 (−11.89%)
Oct 26 4:00 PM ET · prev $0.0681
1 year
−26.8%
from $0.0820 · Oct 27
30 days
−21.6%
from $0.0765
52-week range
$0.0528–0.1400
−57% from high · low Aug 5
Avg volume 20D
16.0K
Oct 8 spike 188.3K
Short interest
🔒 Subscribers only
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Jul 15 Short interest falls 27.6% to 36.6K
- X Jul 31 Short interest jumps 124.2% to 82.0K
- X Aug 14 Short interest falls 72.4% to 22.6K
- X Aug 31 Short interest falls 79.3% to 4.7K
Signal stack
Where each data set points today.
- TrendDOWNTREND
31% below its 50-day average.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 14, 2026 Event
TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Class II: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related t
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 14, 2026
FDA
TIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Class II: Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
Oct 14, 2026
FDA
Tri-MIX (PAPAV/PHENTO/ALPROS),30/1/20, injectable, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936,
Class II: Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Oct 14, 2026
FDA
Tri-MIX (PAPAV/PHENTO/ALPROS),30/1/10, injectable, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936,
Class II: Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Oct 14, 2026
FDA
Tri-MIX (PAPAV/PHENTO/ALPROS),30/1/60, injectable, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Class II: Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Oct 14, 2026
FDA
QUAD-MIX( PAPAV/PHENTO/ALPROS/TROP) INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
Class II: Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short